Forge Valuable Patient Advocacy and Access Alliances throughout Orphan Drug Development and Commercialization
Each year, CBI works collaboratively with NORD to develop a summit in support of a common goal to serve the rare disease community. Building off of a successful four-year history, this summit assembles industry stakeholders and key thought leaders in the rare disease and drug development arena, for an energetic and timely discussion on recent initiatives, reimbursement and patient access challenges, commercialization partnerships, and more. Agenda includes updates from FDA, NIH, Kakkis EveryLife Foundation, plus an inspirational Keynote Address from John F. Crowley, Chairman & CEO, Amicus Therapeutics.
Please visit: www.cbinet.com/raredisease or call 339-298-2100 for details.
Valuable Offer: Mention Promo Code: MRT253 and Save $400*(Offer ends April 16th)
(Discount cannot be combined with any other discounts or used toward a current registration)